| scholarly article | Q13442814 |
| P50 | author | David M. Lukac | Q42383802 |
| P2093 | author name string | Jennifer L DeCotiis | |
| P2860 | cites work | PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of spliced mRNAs | Q24301026 |
| Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs | Q24309306 | ||
| Herpes simplex virus nucleocapsids mature to progeny virions by an envelopment --> deenvelopment --> reenvelopment pathway | Q24529141 | ||
| Egress of alphaherpesviruses: comparative ultrastructural study | Q24529503 | ||
| Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines | Q24533662 | ||
| SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation | Q24548288 | ||
| Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization | Q24648127 | ||
| Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 | ||
| Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 | Q24650743 | ||
| KSHV: pathways to tumorigenesis and persistent infection | Q27026000 | ||
| Structure and Function of the CSL-KyoT2 Corepressor Complex: A Negative Regulator of Notch Signaling | Q27680715 | ||
| KSHV reactivation and novel implications of protein isomerization on lytic switch control | Q28080937 | ||
| Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression. | Q53620977 | ||
| The Theory of the Gene | Q56456417 | ||
| Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995 | Q62489954 | ||
| Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors | Q73067198 | ||
| Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells | Q73854104 | ||
| Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP) | Q76368260 | ||
| HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas | Q77585009 | ||
| Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein | Q77760836 | ||
| Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes | Q78860218 | ||
| Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population | Q79772673 | ||
| The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation | Q81304838 | ||
| Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression. | Q35943718 | ||
| Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes. | Q35964857 | ||
| Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection | Q35983048 | ||
| Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein | Q36019173 | ||
| The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc | Q36099076 | ||
| Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway. | Q36167973 | ||
| KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo | Q36185745 | ||
| Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein | Q36315189 | ||
| MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virions | Q36397498 | ||
| The interaction between KSHV RTA and cellular RBP-Jkappa and their subsequent DNA binding are not sufficient for activation of RBP-Jkappa | Q36427142 | ||
| Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. | Q36439695 | ||
| Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing | Q36484026 | ||
| Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency | Q36538689 | ||
| Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus | Q36594106 | ||
| Non-HIV-associated Kaposi's sarcoma of the tongue. Case report and review of the literature | Q36871904 | ||
| Phosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt | Q36978654 | ||
| Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin | Q37010247 | ||
| Toll-like receptor signaling controls reactivation of KSHV from latency | Q37261693 | ||
| The malignant potential of HIV-associated Kaposi sarcoma | Q37314351 | ||
| The Notch signaling pathway: transcriptional regulation at Notch target genes | Q37376057 | ||
| KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features | Q37488130 | ||
| Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus | Q37547223 | ||
| Herpesvirus assembly: an update | Q37570980 | ||
| Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells | Q37634746 | ||
| AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies | Q37636208 | ||
| Virion proteins of Kaposi's sarcoma-associated herpesvirus | Q37744006 | ||
| Canonical and non-canonical Notch ligands | Q37785194 | ||
| Castleman disease: the great mimic. | Q37945564 | ||
| Tegument Proteins of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses | Q37995595 | ||
| Kaposi sarcoma: review and medical management update | Q38017050 | ||
| Interaction of KSHV with host cell surface receptors and cell entry | Q38262354 | ||
| Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. | Q38295126 | ||
| Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells. | Q38315444 | ||
| Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression | Q38319392 | ||
| Notch signaling: from the outside in | Q28139768 | ||
| Glycogen synthase kinase-3beta modulates notch signaling and stability | Q28215000 | ||
| Risk factors for classical Kaposi's sarcoma | Q28215448 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival | Q28272536 | ||
| Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H) | Q28286560 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Primary effusion lymphoma | Q28303700 | ||
| Mind bomb 1 is required for pancreatic β-cell formation | Q28585145 | ||
| The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
| Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia | Q29614269 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction | Q29620054 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation | Q30482603 | ||
| Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule | Q31162666 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Intriguing interplay between viral proteins during herpesvirus assembly or: the herpesvirus assembly puzzle | Q33341874 | ||
| A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus | Q33415884 | ||
| Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection | Q33508240 | ||
| KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia | Q33509506 | ||
| Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45. | Q33582093 | ||
| KSHV-induced notch components render endothelial and mural cell characteristics and cell survival | Q33627013 | ||
| Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression | Q33653424 | ||
| Binding of RBP-Jkappa (CSL) protein to the promoter of the Kaposi's sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein. | Q33664758 | ||
| Thermodynamic analysis of the CSL x Notch interaction: distribution of binding energy of the Notch RAM region to the CSL beta-trefoil domain and the mode of competition with the viral transactivator EBNA2. | Q33673817 | ||
| Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway | Q33737793 | ||
| Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ. | Q33743831 | ||
| A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus | Q33784966 | ||
| Three-dimensional structure of the human herpesvirus 8 capsid | Q33811735 | ||
| Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus | Q33815257 | ||
| A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. | Q33815534 | ||
| Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus | Q33842309 | ||
| Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency | Q33843211 | ||
| DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters | Q33844093 | ||
| Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group | Q33857954 | ||
| Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dis | Q41788529 | ||
| In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. | Q41839438 | ||
| Notch-Jagged complex structure implicates a catch bond in tuning ligand sensitivity. | Q42220831 | ||
| Latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus promotes angiogenesis through targeting notch signaling effector Hey1. | Q42237356 | ||
| Interaction of Kaposi's sarcoma-associated herpesvirus ORF59 with oriLyt is dependent on binding with K-Rta | Q42779536 | ||
| Specific EGF repeats of Notch mediate interactions with Delta and serrate: Implications for notch as a multifunctional receptor | Q42806879 | ||
| FLIP-mediated autophagy regulation in cell death control | Q42832950 | ||
| Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients | Q43823829 | ||
| Use of a claims database to characterize and estimate the incidence rate for Castleman disease | Q43956973 | ||
| Infectious human herpesvirus 8 in a healthy North American blood donor | Q44132374 | ||
| Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. | Q44448784 | ||
| KSHV vFLIP binds to IKK-gamma to activate IKK. | Q44532483 | ||
| Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. | Q44677526 | ||
| Localization of the delta-like-1-binding site in human Notch-1 and its modulation by calcium affinity | Q45345841 | ||
| Salivary shedding of HHV-8 in people infected or not by human immunodeficiency virus 1 | Q45372146 | ||
| Active intranuclear movement of herpesvirus capsids | Q46415497 | ||
| Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells | Q46531701 | ||
| Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3. | Q46659674 | ||
| Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence | Q46798265 | ||
| Kaposi[apos ]s sarcoma in rheumatic diseases | Q35109810 | ||
| KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasome | Q35116456 | ||
| Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling | Q35168476 | ||
| Kaposi's sarcoma-associated herpesvirus ORF6 gene is essential in viral lytic replication | Q35183996 | ||
| HIV-associated multicentric Castleman disease | Q35226470 | ||
| Chromatinization of the KSHV Genome During the KSHV Life Cycle | Q35237492 | ||
| Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. | Q35275001 | ||
| Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1. | Q35479911 | ||
| Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus | Q35635202 | ||
| Notch Transmembrane Domain: Secondary Structure and Topology | Q35755025 | ||
| Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome | Q35795414 | ||
| Insights into Autoregulation of Notch3 from Structural and Functional Studies of Its Negative Regulatory Region | Q35836383 | ||
| Viral interactions with the Notch pathway | Q35853119 | ||
| Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer | Q35857736 | ||
| Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA. | Q35867478 | ||
| Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers | Q35895560 | ||
| Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
| Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency | Q33916507 | ||
| Bone marrow failure associated with human herpesvirus 8 infection after transplantation | Q33924650 | ||
| Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA | Q33980474 | ||
| Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression | Q34084509 | ||
| Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells | Q34124015 | ||
| The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation | Q34130213 | ||
| An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease | Q34157797 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency | Q34194120 | ||
| Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats | Q34195800 | ||
| KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome | Q34270407 | ||
| Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. | Q34338900 | ||
| Immune escape of γ-herpesviruses from adaptive immunity | Q34345549 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells | Q34355092 | ||
| KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors | Q34423454 | ||
| Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs | Q34434808 | ||
| Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability | Q34478018 | ||
| Herpesvirus assembly and egress | Q34499618 | ||
| An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus | Q34501055 | ||
| Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. | Q34501252 | ||
| The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells | Q34511161 | ||
| Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma | Q34544861 | ||
| Transmission of human herpesvirus 8 by blood transfusion. | Q34569442 | ||
| Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. | Q34648229 | ||
| Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines | Q34733560 | ||
| Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression | Q34742851 | ||
| Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling | Q34811698 | ||
| Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation | Q35010647 | ||
| Molecular biology of KSHV lytic reactivation | Q35014918 | ||
| Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection. | Q35075128 | ||
| The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection | Q35077558 | ||
| KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways | Q35079842 | ||
| Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA | Q35080754 | ||
| Notch signaling and inherited disease syndromes | Q35095915 | ||
| Processivity factor of KSHV contains a nuclear localization signal and binding domains for transporting viral DNA polymerase into the nucleus | Q38323238 | ||
| Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling. | Q38340693 | ||
| Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes | Q38348963 | ||
| Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity | Q38359214 | ||
| Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. | Q38359222 | ||
| An easily transfectable cell line that produces an infectious reporter virus for routine and robust quantitation of Kaposi's sarcoma-associated herpesvirus reactivation. | Q38700640 | ||
| Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway | Q38761166 | ||
| The emerging role of Notch pathway in ageing: Focus on the related mechanisms in age-related diseases. | Q38872194 | ||
| Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus | Q38904066 | ||
| PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor | Q38922595 | ||
| Epstein Barr virus - a tumor virus that needs cytotoxic lymphocytes to persist asymptomatically | Q38945578 | ||
| Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL. | Q38959859 | ||
| RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner | Q39321282 | ||
| KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. | Q39426922 | ||
| Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle. | Q39575256 | ||
| Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells | Q39596534 | ||
| Discovery of a viral NLR homolog that inhibits the inflammasome | Q39604966 | ||
| Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate | Q39606465 | ||
| Notch3 gene amplification in ovarian cancer | Q39759149 | ||
| Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. | Q39794624 | ||
| Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis | Q39833695 | ||
| The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. | Q39860135 | ||
| Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway | Q39860632 | ||
| The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions | Q39877021 | ||
| A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation | Q39897858 | ||
| Kaposi's sarcoma-associated herpesvirus gH/gL: glycoprotein export and interaction with cellular receptors. | Q39926353 | ||
| Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. | Q40002946 | ||
| Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication | Q40021229 | ||
| Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network | Q40041837 | ||
| Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivati | Q40126113 | ||
| Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro | Q40267803 | ||
| Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency | Q40279784 | ||
| KSHV RTA induces a transcriptional repressor, HEY1 that represses rta promoter | Q40283008 | ||
| Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells | Q40426996 | ||
| The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. | Q40461940 | ||
| A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES. | Q40537403 | ||
| RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA | Q40546002 | ||
| Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements | Q40572745 | ||
| Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection | Q40598301 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication | Q40644381 | ||
| Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus | Q40721382 | ||
| Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells | Q40749885 | ||
| Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties | Q40802330 | ||
| Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication | Q40909738 | ||
| Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma | Q40972068 | ||
| Kaposi's sarcoma in organ transplant recipients: report of 20 cases | Q41593468 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2017-08-04 | |
| P1433 | published in | Pathogens | Q27724554 |
| P1476 | title | KSHV and the Role of Notch Receptor Dysregulation in Disease Progression | |
| P478 | volume | 6 |
| Q49637887 | BioMuta and BioXpress: mutation and expression knowledgebases for cancer biomarker discovery. |
| Q90089117 | Oncolytic HSV-Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition |
| Q55518093 | Primary effusion lymphoma: current perspectives. |
| Q92257146 | Transcriptional and post-transcriptional regulation of viral gene expression in the gamma-herpesvirus Kaposi's sarcoma-associated herpesvirus |
Search more.